Evolent Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Evolent Health, Inc. on November 3, 2015, covering events that occurred on November 1, 2015. The filing primarily addresses corporate governance changes regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel and governance matters rather than financial performance.
Material Changes
- Board Expansion: The Board of Directors increased the number of directors from nine to ten.
- New Appointment: Cheryl Scott was appointed as a new director.
- Committee Assignment: Ms. Scott was appointed to the Audit Committee, having met NYSE financial literacy and experience requirements.
- Independence: The Board determined Ms. Scott is an independent director under NYSE Corporate Governance Standards and meets SEC independence requirements for the Audit Committee.
Management Commentary and Risks
Ms. Scott brings significant healthcare experience, having served as a Senior Advisor for Global Programs at the Bill & Melinda Gates Foundation since 2007 and as its Chief Operating Officer from 2006 to 2007. Previously, she was President and CEO of Group Health Cooperative from 1997 to 2005. There were no special arrangements or understandings regarding her selection. She will receive standard director indemnification and participate in compensation programs for non-employee directors. No unusual items or specific risks were disclosed in this filing.
Investor Verification Checklist
- Verify Cheryl Scott's full resume and prior board affiliations.
- Confirm the updated composition of the Audit Committee in subsequent filings.
- Review the press release (Exhibit 99.1) for additional context on the appointment.
- Check for any related party transactions involving Ms. Scott in future Item 404 disclosures.